Quest Diagnostics Could Be Your Golden Lab

The 2014 implementation of Obama Care should provide major stimulus for the overall volume of lab work as at least 30 million people become newly covered patients. Industry leader Quest Diagnostics (DGX) is likely to be a big beneficiary.

Quest shares took a big stumble last week after Q4 earnings and revenue came in light. Management claims 6 cents of the fourth quarter disappointment was non-recurring and caused by business lost due to Hurricane Sandy. The stock has retreated from an all-time peak of $64.87 last October. Quest was $62 as recently as Jan. 18. Quest closed at $58.26 Tuesday, an area of solid technical support. The shares got as low as $57.03 intraday....323 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.